Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 700-253-3 | CAS number: 115258-10-1
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vivo (LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2009-10-26 to 2010-01-11
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: Well performed GLP-study according to OECD testing guide line.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 010
- Report date:
- 2010
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)
- Version / remarks:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.42 (Skin Sensitisation: Local Lymph Node Assay)
- Version / remarks:
- no
- GLP compliance:
- yes (incl. QA statement)
- Remarks:
- Certificate attached to full study report
- Type of study:
- mouse local lymph node assay (LLNA)
Test material
- Reference substance name:
- N-(3-{1,1,1,5,5,5-hexamethyl-3-[(trimethylsilyl)oxy]trisiloxan-3-yl}propyl)prop-2-enamide
- EC Number:
- 700-253-3
- Cas Number:
- 115258-10-1
- Molecular formula:
- C15H37NO4Si4
- IUPAC Name:
- N-(3-{1,1,1,5,5,5-hexamethyl-3-[(trimethylsilyl)oxy]trisiloxan-3-yl}propyl)prop-2-enamide
Constituent 1
In vivo test system
Test animals
- Species:
- mouse
- Strain:
- other: CBA/J@Rj
- Sex:
- female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: Elevage Janvier (F-53941 Le Genest Saint Isle)
- Age at study initiation: 8 weeks
- Animals were nulliparous and non-pregnant
- Weight at study initiation: 20.3 - 24.5g
- Housing: suspended solid-floor polypropylene cages furnished with soft woodflakes
- Diet (e.g. ad libitum): ad libitum
- Water (e.g. ad libitum): tap water, ad libitum
- Acclimation period: 5 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 19-25°C
- Humidity (%): 30-70
- Air changes (per hr): 15
- Photoperiod (hrs dark / hrs light): 12hrs / 12hrs
- Animals were provided with environmental enrichment items which were considered not to contain any contaminant of a level that might have affected the purpose or integrity of the study
Study design: in vivo (LLNA)
- Vehicle:
- acetone/olive oil (4:1 v/v)
- Concentration:
- 0% (vehicle control), 10%, 25%, 50% (as the test item was a powder, the maximum tested dose was 50%)
- No. of animals per dose:
- 4 females
- Details on study design:
- PRELIMINARY STUDY
- Preliminary screening using one mouse
- The mouse was treated with 25µL of the undiluted test item
- Dorsal surface of each ear was treated on three consecutive days (d1, d2, d3)
- Daily observation of the treated animal on d1, d2, d3, d4, d5 and d6
- Any signs of toxicity or excessive local irritation noted during this period were recorded
- Body weight was recorded on day 1 prior to treatment and on day 6
- No systemic toxicity or excessive local reactions observed
MAIN STUDY
- Groups of four mice per each concentration
- Group 1: 4 females with vehicle only --> 0% of test item
- Group 2: 4 females with 10% test item
- Group 3: 4 females with 25% test item
- Group 4: 4 females with 50% test item
- An additional mouse was treated in each group in case of problems which may occur during the study, in particular during excision of lymph nodes
- Mice were treated by daily application of 25µL of the appropriate concentration of the test item to the dorsal surface of each ear for three consecutive days
- Test item formulation was administered using an automatic micropipette and spread over the dorsal surface using the tip of the pipette
ANIMAL ASSIGNMENT AND TREATMENT
- Name of test method: Ear thickness and cell proliferation
- See specific details under: "Any other information on materials and methods incl. tables"
CRITERIA USED TO CONSIDER A POSITIVE RESPONSE:
- The test item will be regarded as a sensitiser if at least one concentration of the test item results is greater than 1.4 compared to control values
- Any test item failing to produce a SI<1.4 will be classified as a "non sensitiser"
- % increase in ear thickness between day 1 and day 6 - Positive control substance(s):
- hexyl cinnamic aldehyde (CAS No 101-86-0)
Results and discussion
- Positive control results:
- See attached tables (historical controls)
In vivo (LLNA)
Resultsopen allclose all
- Parameter:
- SI
- Remarks on result:
- other: SI calculated by pooled approach was: 1.23 (10%), 1.03 (25%), 1.05 (50%) i.e. no stimulation index of more than 1.4 was recorded for either of the three concentrations
- Parameter:
- other: disintegrations per minute (DPM)
- Remarks on result:
- other: Other method: cell counting and ear thickness
Any other information on results incl. tables
Preliminary screening test
Clinical observations, bodyweight and mortality data are given in Table 1 (attached).
No signs of systemic toxicity were noted.
Based on this information the dose levels selected for the main test were 10% (v/v), 25% (v/v) and50% (w/w) in acetone/olive oil (4:1, v/v).
Main Test
Clinical observations and mortality
Individual clinical observations and mortality data for test and control animals are given in Table 2 (attached).
No mortality and no signs of systemic toxicity were noted in the test and controls animals during thetest.
Weight evolution
Individual bodyweights and bodyweight changes for test and control animals are given in Table 3 (attached).
The body weight evolution revealed an absence of body weight gain in the animals treated at theconcentration of 10% and a slight decrease in the body weight of the animals treated at theconcentrations of 25% and 50% (-9.5% and -9.1% compared to day 1, respectively).
Estimation of the proliferative response of lymph node cells
The results of proliferation assay are given in Table 4 (given here and also attached).
Groups |
Test item |
Cell count / groups |
Stimulation Index |
Result |
EC1.4value |
1 |
AOO (acetone/olive oil, 4:1, v/v) |
22.36 |
n.a |
n.a |
n.a. |
2 |
10% |
27.43 |
1.23 |
Negative |
n.a. |
3 |
25% |
22.96 |
1.03 |
Negative |
|
4 |
50% |
23.38 |
1.05 |
Negative |
Stimulation Index = Cell count of treated group / Cell count of control group
EC1.4 value: Theorical concentration resulting in a SI value of 1.4
EC1.4=c + [(1.4 – d) / (b – d)] x (a – c)
Legend:
a = the lowest concentration giving stimulation index > 1.4
b = the actual stimulation index caused by a
c = the highest concentration failing to produce a stimulation index of 1.4
d = the actual stimulation index caused by c
No stimulation index of more than 1.4 was recorded for the three concentrations of the test item.
The Stimulation Index (SI) calculated by pooled approach was respectively 1.23, 1.03 and 1.05 for the treated group at 10%, 25% and 50%.
Local irritation
The results of ear thickness measurement and weight of skin biopsy are given in Tables 5 and 6 (both attached).
No cutaneous reactions were observed at the concentrations of 10%, 25% and 50%.
No significant increase in ear thickness and in ear weight was recorded at the concentrations of 10%, 25% and 50%. Therefore, the test item must be considered “non irritant” at the three concentrations.
Applicant's summary and conclusion
- Interpretation of results:
- not sensitising
- Remarks:
- Migrated information
- Conclusions:
- In view of these results, under these experimental conditions, the test item N-[3- tris(trimethylsilyloxy)silylpropyl]prop-2-enamide is considered to be not a skin sensitiser, in accordance with the criteria for classification, packaging and labelling of dangerous substances and preparations of the E.E.C. Directives 67/548, 2001/59 and 99/45. No symbol and risk phrase are required.
In accordance with the Globally Harmonized System (Regulation (EC) No. 1272/2008), the test item is not to be classified. No signal word and hazard statement are required. - Executive summary:
The test was performed to assess the skin sensitisation potential of the test item N-[3-tris(trimethylsilyloxy)silyl)silylpropyl]prop-2 -enamide in the CBA/J strain mouse following topicalapplications to the dorsal surface of the ear.
Three groups of four animals, were treated for three consecutive days (D1, D2, D3) with 50 µL (25 µLper ear) of the test item as a solution in acetone/olive oil (4:1, v/v) (AOO) at concentrations of 10%,25% and 50% (v/v). A further group of four animals was treated with AOO.
On D6, the proliferation of lymphocytes in the draining auricular lymph nodes was determined by cell counting. The experimental protocol was established according the OECD Guideline n°429 dated April 24th, 2002 and the test method B.42 of the council regulation No.440/2008.
No mortality and no signs of systemic toxicity were noted in the test and control animals during the test.
The body weight evolution revealed an absence of body weight gain in the animals treated at the concentration of 10% and a slight decrease in the body weight of the animals treated at the concentrations of 25% and 50% (-9.5% and -9.1% compared to day 1, respectively).
No cutaneous reaction was observed.
No significant increase in ear thickness and in ear weight was recorded at the concentrations of 10%, 25% and 50%. Therefore, the test item must be considered “non irritant” at the three concentrations.
The Stimulation Index (SI) calculated by pooled approach was1.23, 1.03 and 1.05 for the treated groups at 10%, 25% and 50%, respectively.
In view of these results, under these experimental conditions, the test item N-[3 -tris(trimethylsilyloxy)silyl)silylpropyl]prop-2 -enamide is considered to be not a skin sensitiser, in accordance with the criteria for classification, packaging and labelling of dangerous substances and preparations of the E.E.C. Directives 67/548, 2001/59 and 99/45. No symbol and risk phrase are required.
In accordance with the Globally Harmonized System (Regulation (EC) No 1272/2008), the test item is not to be classified. No signal word and hazard statement are required.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.